EMEA-000005-PIP01-07-M01

Key facts

Invented name
Diovan
Active substance
valsartan
Therapeutic area
Cardiovascular diseases
Decision number
P/125/2009
PIP number
EMEA-000005-PIP01-07-M01
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate liquid dosage form
Condition(s) / indication(s)
  • Heart failure following recent myocardial infarction
  • Treatment of heart failure
  • Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Limited

E-mail: paediatric.enquiries@novartis.com
Tel. +41 6132 41111

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000005-PIP01-07-M01
Compliance opinion date
21/08/2009
Compliance outcome
positive

Decision

How useful was this page?

Add your rating
Average
1 rating